Severe postpartum haemorrhage treated with recombinant activated Factor VII in 80 Czech patients: analysis of the UniSeven registry
| Authors | |
|---|---|
| Year of publication | 2011 |
| Type | Article in Periodical |
| Magazine / Source | International journal of obstetric anesthesia |
| MU Faculty or unit | |
| Citation | |
| Doi | http://dx.doi.org/10.1016/j.ijoa.2011.07.008 |
| Field | Gynaecology and obstetrics |
| Keywords | UniSeven registry; postpartum haemorrhage |
| Description | All cases between 2004 and 2009 in which rFVIIa was used to treat PPH in Czech patients without a primary coagulation defect were identified. Demographic and clinical data were extracted from the selected records (these were incomplete in three cases) and compared in women who received rFVIIa before proposed hysterectomy and those who were given rFVIIa during or after hysterectomy. Treatment with rFVIIa was considered to be effective if the patient survived; saving the uterus was considered to be a secondary benefit of treatment. |